Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term receptor. Found 70 abstracts

no pagination
Mookerjee-Basu J, Kappes DJ. iNKT cells do a fat lot of good. Nature immunology. 2017 Jan;18(1):10-2.
Rizzolio F, Caligiuri I, Lucchetti C, Fratamico R, Tomei V, Gallo G, Agelan A, Ferrari G, Toffoli G, Klein-Szanto AJ, Giordano A. Dissecting Pin1 and phospho-pRb regulation. Journal of cellular physiology. 2013 Jan;228(1):73-7.   PMCID: not NIH funded
Cao Y, Marks JD, Huang Q, Rudnick SI, Xiong CY, Hittelman WN, Wen XX, Marks JW, Cheung LH, Boland K, Li C, Adams GP, Rosenblum MG. Single-Chain Antibody-Based Immunotoxins Targeting Her2/neu: Design Optimization and Impact of Affinity on Antitumor Efficacy and Off-Target Toxicity. Molecular Cancer Therapeutics. 2012 Jan;11(1):143-53.
Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen XQ, Wang XS, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, Andrulis IL, Ozcelik H, Mulligan AM, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Caligo MA, von Wachenfeldt A, Barbany-Bustinza G, Loman N, Soller M, Ehrencrona H, Karlsson P, Nathanson KL, Rebbeck TR, Domchek SM, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Huzarski T, Byrski T, Gronwald J, Cybulski C, Gorski B, Osorio A, Duran M, Tejada MI, Benitez J, Hamann U, Hogervorst FB, van Os TA, van Leeuwen FE, Meijers-Heijboer HE, Wijnen J, Blok MJ, Kets M, Hooning MJ, Oldenburg RA, Ausems M, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Jacobs C, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Paterson J, Brewer C, Douglas F, Hodgson SV, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Side LE, Bove B, Godwin AK, Stoppa-Lyonnet D, Fassy-Colcombet M, Castera L, Cornelis F, Mazoyer S, Leone M, Boutry-Kryza N, Bressac-de Paillerets B, Caron O, Pujol P, Coupier I, Delnatte C, Akloul L, Lynch HT, Snyder CL, Buys SS, Daly MB, Terry M, Chung WK, John EM, Miron A, Southey MC, Hopper JL, Goldgar DE, Singer CF, Rappaport C, Tea MK, Fink-Retter A, Hansen TV, Nielsen FC, Arason A, Vijai J, Shah S, Sarrel K, Robson ME, Piedmonte M, Phillips K, Basil J, Rubinstein WS, Boggess J, Wakeley K, Ewart-Toland A, Montagna M, Agata S, Imyanitov EN, Isaacs C, Janavicius R, Lazaro C, Blanco I, Feliubadalo L, Brunet J, Gayther SA, Pharoah PP, Odunsi KO, Karlan BY, Walsh CS, Olah E, Teo SH, Ganz PA, Beattie MS, van Rensburg EJ, Dorfling CM, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Heinritz W, Caldes T, de la Hoya M, Muranen TA, Nevanlinna H, Tischkowitz M, Spurdle AB, Neuhausen SL, Ding YC, Lindor NM, Fredericksen Z, Pankratz VS, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Bernard L, Viel A, Giannini G, Varesco L, Radice P, Greene MH, Mai PL, Easton DF, Chenevix-Trench G, Offit K, Simard J. Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 2012 Apr;21(4):645-57.   PMCID: PMC3319317
Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Shani Paluch S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Gronwald J, Huzarski T, Cybulski C, Byrski T, Osorio A, Cajal TR, Stavropoulou AV, Benitez J, Hamann U, Rookus M, Aalfs CM, de Lange JL, Meijers-Heijboer HE, Oosterwijk JC, van Asperen CJ, Garcia EB, Hoogerbrugge N, Jager A, van der Luijt RB, Easton DF, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Izatt L, Eeles R, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Brewer C, Tischkowitz M, Godwin AK, Pathak H, Stoppa-Lyonnet D, Sinilnikova OM, Mazoyer S, Barjhoux L, Leone M, Gauthier-Villars M, Caux-Moncoutier V, de Pauw A, Hardouin A, Berthet P, Dreyfus H, Ferrer SF, Collonge-Rame MA, Sokolowska J, Buys S, Daly M, Miron A, Terry MB, Chung W, John EM, Southey M, Goldgar D, Singer CF, Tea MK, Gschwantler-Kaulich D, Fink-Retter A, Hansen TV, Ejlertsen B, Johannsson OT, Offit K, Sarrel K, Gaudet MM, Vijai J, Robson M, Piedmonte MR, Andrews L, Cohn D, DeMars LR, DiSilvestro P, Rodriguez G, Toland AE, Montagna M, Agata S, Imyanitov E, Isaacs C, Janavicius R, Lazaro C, Blanco I, Ramus SJ, Sucheston L, Karlan BY, Gross J, Ganz PA, Beattie MS, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Nevanlinna H, Aittomaki K, Simard J, Spurdle AB, Beesley J, Chen XQ, Tomlinson GE, Weitzel J, Garber JE, Olopade OI, Rubinstein WS, Tung N, Blum JL, Narod SA, Brummel S, Gillen DL, Lindor N, Fredericksen Z, Pankratz VS, Couch FJ, Radice P, Peterlongo P, Greene MH, Loud JT, Mai PL, Andrulis IL, Glendon G, Ozcelik H, Gerdes AM, Thomassen M, Jensen UB, Skytte AB, Caligo MA, Lee A, Chenevix-Trench G, Antoniou AC, Neuhausen SL. A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers. Cancer Epidemiology Biomarkers & Prevention. 2012 Aug;21(8):1362-70.   PMCID: PMC3415567
Engel I, Zhao M, Kappes D, Taniuchi I, Kronenberg M. The transcription factor Th-POK negatively regulates Th17 differentiation in V alpha 14i NKT cells. Blood. 2012 Nov;120(23):4524-32.   PMCID: PMC3512232
Motzer RJ, Hutson TE, Olsen MR, Hudes GR, Burke JM, Edenfield WJ, Wilding G, Agarwal N, Thompson JA, Cella D, Bello A, Korytowsky B, Yuan JY, Valota O, Martell B, Hariharan S, Figlin RA. Randomized Phase II Trial of Sunitinib on an Intermittent Versus Continuous Dosing Schedule As First-Line Therapy for Advanced Renal Cell Carcinoma. Journal of Clinical Oncology. 2012 Apr;30(12):1371-7.   PMCID: not NIH funded
Skarbnik AP, Smith MR. Brentuximab vedotin in anaplastic large cell lymphoma. Expert Opinion on Biological Therapy. 2012 May;12(5):633-9.   PMCID: *
Smith ER, Yeasky T, Wei JQ, Miki RA, Cai KQ, Smedberg JL, Yang WL, Xu XX. White spotting variant mouse as an experimental model for ovarian aging and menopausal biology. Menopause-the Journal of the North American Menopause Society. 2012 May;19(5):588-96.   PMCID: PMC3326177
Tchou J, Wang LC, Selven B, Zhang HT, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Mesothelin, a novel immunotherapy target for triple negative breast cancer. Breast Cancer Research and Treatment. 2012 Jun;133(2):799-804.
Gong Y, Huo L, Liu P, Sneige N, Sun X, Ueno NT, Lucci A, Buchholz TA, Valero V, Cristofanilli M. Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer. 2011 Dec;117(24):5476-84.   PMCID: not NIH funded
Pectasides E, Rampias T, Kountourakis P, Sasaki C, Kowalski D, Fountzilas G, Zaramboukas T, Rimm D, Burtness B, Psyrri A. Comparative Prognostic Value of Epidermal Growth Factor Quantitative Protein Expression Compared with FISH for Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 2011 May;17(9):2947-54.   PMCID: not NIH funded
Sparano JA, Goldstein LJ, Childs BH, Shak S, Brassard D, Badve S, Baehner FL, Bugarini R, Rowley S, Perez EA, Shulman LN, Martino S, Davidson NE, Kenny PA, Sledge GW, Gray R. Relationship between Quantitative GRB7 RNA Expression and Recurrence after Adjuvant Anthracycline Chemotherapy in Triple-Negative Breast Cancer. Clinical Cancer Research. 2011 Nov;17(22):7194-203.   PMCID: PMC3570203
Stadanlick JE, Zhang ZQ, Lee SY, Hemann M, Biery M, Carleton MO, Zambetti GP, Anderson SJ, Oravecz T, Wiest DL. Developmental Arrest of T Cells in Rpl22-Deficient Mice Is Dependent upon Multiple p53 Effectors. Journal of Immunology. 2011 Jul;187(2):664-75.   PMCID: PMC3131471
Boorjian SA, Zhu F, Herr HW. The effect of gender on response to bacillus Calmette-Guerin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder. BJU international. 2010 Aug;106(3):357-61.   PMCID: *
Burris HA, Rosen LS, Rocha-Lima CM, Marshall J, Jones S, Cohen RB, Kunkel LA, Loo D, Baughman J, Stewart SJ, Lewis N. Phase 1 Experience with an Anti-Glycotope Monoclonal Antibody, RAV12, in Recurrent Adenocarcinoma. Clinical Cancer Research. 2010 Mar;16(5):1673-81.   PMCID: not NIH funded
Hsu PY, Hsu HK, Singer GA, Yan PS, Rodriguez BA, Liu JC, Weng YI, Deatherage DE, Chen Z, Pereira JS, Lopez R, Russo J, Wang QB, Lamartiniere CA, Nephew KP, Huang TH. Estrogen-mediated epigenetic repression of large chromosomal regions through DNA looping. Genome Research. 2010 Jun;20(6):733-44.   PMCID: PMC2877570
Jin Y, Xia MC, Saylor CM, Narayan K, Kang J, Wiest DL, Wang YM, Xiong N. Cutting Edge: Intrinsic Programming of Thymic gamma delta T Cells for Specific Peripheral Tissue Localization. Journal of Immunology. 2010 Dec;185(12):7156-60.   PMCID: PMC3023158
Kelly DF, Lake RJ, Middelkoop TC, Fan HY, Artavanis-Tsakonas S, Walz T. Molecular Structure and Dimeric Organization of the Notch Extracellular Domain as Revealed by Electron Microscopy. Plos One. 2010 May;5(5).   PMCID: PMC2866536
Tong X, Zitserman D, Serebriiskii I, Andrake M, Dunbrack R, Roegiers F. Numb Independently Antagonizes Sanpodo Membrane Targeting and Notch Signaling in Drosophila Sensory Organ Precursor Cells. Molecular Biology of the Cell. 2010 Mar;21(5):802-10.   PMCID: PMC2828966 (available 5/16/2010)
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term receptor

receptor expression in-vivo cancer disease breast-cancer kinase lineage gene survival carcinoma monoclonal-antibody localization protein inhibitor neu-overexpressing metastatic breast 8q24 1989 audhary vk-nature-v339-p394 non-hodgkins-lymphoma interferon-alpha dna-repair embryonic stem-cells cells recognition her2 animal toxicity gene-expression randomized trial genetic-variation ALK ALCL-anaplastic large cell lymphoma-antibody-drug conjugate-brentuximab vedotin-CD30-MMAE-non-Hodgkin lymphoma-SGN-35-T-cell lymphoma monolayer purification phase-ii alpha-adaptin growth risk 2002 llo sp-biol chem-v383-p69 signal integration marker validation insulin-resistance natural-killer rb chromatin immunoprecipitation ror-gamma-t k1 progenitor survival plus cetuximab dna-damage enhancer immunotherapy colorectal-cancer family peptide fate determinant numb small-intestine solid tumors histone h3 retinoblastoma susceptibility gene positive human epidermal growth factor receptor 2 asymmetric divisions locus endocytic protein alleles messenger-rna basal-like subtype amino-acid polymorphism histone methyltransferase ezh2 1995 ng cx-v82-p675 subtypes insulin product pathway cell-cycle polymerase chain-reaction reproductive factors fibroblast-growth-factor childhood 1995 bruin pc-leukemia-v9-p1620 Mycobacterium bovis carcinogenesis mouse estrogen Ovarian follicles Menopause-Germ cells-c-kit-Wv mice-Mouse model prolyl ptb domain urinary-bladder su11248 egf repeats 1991 kahashi ja-febs letters-v288-p65 sex steroids copy number alterations prostate-cancer obesity phase-ii trial amplification wide isomerase pin1 internalization ki-1 lymphoma 1000 bchy a-clin canc res-v16-p5351 tissue microarray analysis urothelial cell suppressor 1989 caprio ja-cell-v58-p1085 carcinomas epithelial-cells recombinant immunotoxin tumor subtypes inflammatory breast cancer tcr signals invariant nkt cells features transitional-cell carcinoma 1992 ang k-american journal of surgical pathology-v16-p259 susceptibility loci hairless zeste homolog-2 solid cancer risk homeostasis lethal-giant-larvae in-situ pre-tcr perimenopause tumors cpg-island methylation cancer-therapy lineage commitment selection produce il-17 enhancer of zeste homolog 2 BCG proteins drosophila consortium 1989 en pl-cell-v58-p1193 spermatogonial stem-cells apoptotic pathways hypermethylation basal uric-acid nephrolithiasis primordial germ-cells igf ribosomal-protein l26 growth-factor-i kit bh3-only proteins positive selection neoplasia
Last updated on Tuesday, July 03, 2018